Reference

CEM_CMO(2022)007

Name

COVID-19 Therapeutic Alert: Baricitinib for patients hospitalised due to COVID-19 (adults and children aged 2 years and over)

Categories

Scottish Government CMO Letters

Organization

Scottish Government Health and Social Care Directorates

Keywords

NHS SCOTLAND COVID-19 CORONAVIRUS TREATMENTS DRUGS PATIENTS HOSPITALS HEALTHCARE PROFESSIONALS ADULTS ADOLESCENTS

Description

Baricitinib is recommended to be available as a treatment option through routine commissioning for adults and children (aged 2 years and over) hospitalised with COVID-19 in accordance with the criteria set out in this document. Use of baricitinib in the treatment of COVID-19 is off-label.

Contact Name

Irene Fazakerley

Contact Email

Contact Address

St Andrew’s House Regent Road Edinburgh EH1 3DG

Contact Phone

Created

2022-05-05 00:00:00

Download URL